| Literature DB >> 25621899 |
Ryan K C Yuen1, Bhooma Thiruvahindrapuram1, Daniele Merico1, Susan Walker1, Kristiina Tammimies2, Ny Hoang3, Christina Chrysler4, Thomas Nalpathamkalam1, Giovanna Pellecchia1, Yi Liu5, Matthew J Gazzellone1, Lia D'Abate1, Eric Deneault1, Jennifer L Howe1, Richard S C Liu1, Ann Thompson4, Mehdi Zarrei1, Mohammed Uddin1, Christian R Marshall6, Robert H Ring7, Lonnie Zwaigenbaum8, Peter N Ray9, Rosanna Weksberg10, Melissa T Carter11, Bridget A Fernandez12, Wendy Roberts13, Peter Szatmari14, Stephen W Scherer15.
Abstract
Autism spectrum disorder (ASD) is genetically heterogeneous, with evidence for hundreds of susceptibility loci. Previous microarray and exome-sequencing studies have examined portions of the genome in simplex families (parents and one ASD-affected child) having presumed sporadic forms of the disorder. We used whole-genome sequencing (WGS) of 85 quartet families (parents and two ASD-affected siblings), consisting of 170 individuals with ASD, to generate a comprehensive data resource encompassing all classes of genetic variation (including noncoding variants) and accompanying phenotypes, in apparently familial forms of ASD. By examining de novo and rare inherited single-nucleotide and structural variations in genes previously reported to be associated with ASD or other neurodevelopmental disorders, we found that some (69.4%) of the affected siblings carried different ASD-relevant mutations. These siblings with discordant mutations tended to demonstrate more clinical variability than those who shared a risk variant. Our study emphasizes that substantial genetic heterogeneity exists in ASD, necessitating the use of WGS to delineate all genic and non-genic susceptibility variants in research and in clinical diagnostics.Entities:
Mesh:
Year: 2015 PMID: 25621899 DOI: 10.1038/nm.3792
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440